New insider activity at Hims & Hers Health ( (HIMS) ) has taken place on December 10, 2025.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Director Andrea G Perez Garcia has recently sold 2,500 shares of Hims & Hers Health stock, amounting to a transaction worth $97,925.
Recent Updates on HIMS stock
In the last 24 hours, Hims & Hers Health (HIMS) has experienced moderate bullish activity despite a slight decrease in share price, with shares down $1.97 to approximately $37.85. The options market shows a relatively light volume with a put/call ratio of 0.68, indicating a modestly bullish sentiment. Implied volatility has increased slightly, suggesting a potential daily price movement. Barclays has initiated coverage with an Overweight rating, citing that the concerns around the company’s compounding strategy are now better understood, leading to more reasonable expectations. The firm also highlights the addition of new growth drivers, which are expected to support sustainable growth through FY26. Additionally, Hims & Hers has expanded its weight loss program to the UK, offering new treatment options and transparent pricing, which could further bolster its market presence.
Spark’s Take on HIMS Stock
According to Spark, TipRanks’ AI Analyst, HIMS is a Neutral.
Hims & Hers Health’s strong financial performance and positive earnings call guidance are offset by technical indicators suggesting bearish momentum and a high P/E ratio indicating overvaluation. The new share buyback program adds a positive strategic element, but high leverage remains a concern.
To see Spark’s full report on HIMS stock, click here.
More about Hims & Hers Health
YTD Price Performance: 58.02%
Average Trading Volume: 26,832,036
Technical Sentiment Signal: Hold
Current Market Cap: $8.91B